These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

285 related articles for article (PubMed ID: 30264164)

  • 1. A prospective, interventional, randomized, double-blind, placebo-controlled clinical study to evaluate the efficacy and safety of Bacillus coagulans LBSC in the treatment of acute diarrhea with abdominal discomfort.
    Maity C; Gupta AK
    Eur J Clin Pharmacol; 2019 Jan; 75(1):21-31. PubMed ID: 30264164
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy and safety of Bacillus coagulans LBSC in irritable bowel syndrome: A prospective, interventional, randomized, double-blind, placebo-controlled clinical study [CONSORT Compliant].
    Gupta AK; Maity C
    Medicine (Baltimore); 2021 Jan; 100(3):e23641. PubMed ID: 33545934
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bacillus coagulans MTCC 5856 supplementation in the management of diarrhea predominant Irritable Bowel Syndrome: a double blind randomized placebo controlled pilot clinical study.
    Majeed M; Nagabhushanam K; Natarajan S; Sivakumar A; Ali F; Pande A; Majeed S; Karri SK
    Nutr J; 2016 Feb; 15():21. PubMed ID: 26922379
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy and Safety of
    Rathi A; Pagare R
    Glob Adv Integr Med Health; 2024; 13():27536130241286511. PubMed ID: 39295947
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of Bacillus coagulans Unique IS2 in treatment of irritable bowel syndrome in children: a double blind, randomised placebo controlled study.
    Sudha MR; Jayanthi N; Aasin M; Dhanashri RD; Anirudh T
    Benef Microbes; 2018 Jun; 9(4):563-572. PubMed ID: 29695183
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bacillus coagulans Unique IS2 in Constipation: A Double-Blind, Placebo-Controlled Study.
    Madempudi RS; Neelamraju J; Ahire JJ; Gupta SK; Shukla VK
    Probiotics Antimicrob Proteins; 2020 Jun; 12(2):335-342. PubMed ID: 30911991
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Randomized, double-blind, placebo-controlled clinical trial of loperamide plus simethicone versus loperamide alone and simethicone alone in the treatment of acute diarrhea with gas-related abdominal discomfort.
    Hanauer SB; DuPont HL; Cooper KM; Laudadio C
    Curr Med Res Opin; 2007 May; 23(5):1033-43. PubMed ID: 17519069
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Loperamide-simethicone vs loperamide alone, simethicone alone, and placebo in the treatment of acute diarrhea with gas-related abdominal discomfort. A randomized controlled trial.
    Kaplan MA; Prior MJ; Ash RR; McKonly KI; Helzner EC; Nelson EB
    Arch Fam Med; 1999; 8(3):243-8. PubMed ID: 10333820
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A prospective, randomized, double-blind, placebo-controlled parallel-group dual site trial to evaluate the effects of a Bacillus coagulans-based product on functional intestinal gas symptoms.
    Kalman DS; Schwartz HI; Alvarez P; Feldman S; Pezzullo JC; Krieger DR
    BMC Gastroenterol; 2009 Nov; 9():85. PubMed ID: 19922649
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A randomized double-blind placebo-controlled clinical trial on efficacy and safety of association of simethicone and Bacillus coagulans (Colinox®) in patients with irritable bowel syndrome.
    Urgesi R; Casale C; Pistelli R; Rapaccini GL; de Vitis I
    Eur Rev Med Pharmacol Sci; 2014; 18(9):1344-53. PubMed ID: 24867512
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A randomized placebo-controlled clinical trial of a multi-strain probiotic formulation (Bio-Kult®) in the management of diarrhea-predominant irritable bowel syndrome.
    Ishaque SM; Khosruzzaman SM; Ahmed DS; Sah MP
    BMC Gastroenterol; 2018 May; 18(1):71. PubMed ID: 29801486
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of Bacillus coagulans (Heyndrickxia coagulans)BCP92 in managing irritable bowel syndrome: A randomized, double-blind, multicenter, placebo-controlled clinical trial.
    Shaikh SS; Kumar S
    Medicine (Baltimore); 2024 Aug; 103(31):e39134. PubMed ID: 39093754
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bacillus coagulans significantly improved abdominal pain and bloating in patients with IBS.
    Hun L
    Postgrad Med; 2009 Mar; 121(2):119-24. PubMed ID: 19332970
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy and Safety of Lactobacillus plantarum DSM 9843 (LP299V) in the Prevention of Antibiotic-Associated Gastrointestinal Symptoms in Children-Randomized, Double-Blind, Placebo-Controlled Study.
    Olek A; Woynarowski M; Ahrén IL; Kierkuś J; Socha P; Larsson N; Önning G
    J Pediatr; 2017 Jul; 186():82-86. PubMed ID: 28438377
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A prospective, randomized, double-blind, placebo-controlled, parallel-group study to evaluate the efficacy and safety of SNZ TriBac, a three-strain Bacillus probiotic blend for undiagnosed gastrointestinal discomfort.
    Soman RJ; Swamy MV
    Int J Colorectal Dis; 2019 Nov; 34(11):1971-1978. PubMed ID: 31686199
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of a proprietary Bacillus coagulans preparation on symptoms of diarrhea-predominant irritable bowel syndrome.
    Dolin BJ
    Methods Find Exp Clin Pharmacol; 2009 Dec; 31(10):655-9. PubMed ID: 20140275
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Randomized clinical trial: the effect of probiotic Bacillus coagulans Unique IS2 vs. placebo on the symptoms management of irritable bowel syndrome in adults.
    Madempudi RS; Ahire JJ; Neelamraju J; Tripathi A; Nanal S
    Sci Rep; 2019 Aug; 9(1):12210. PubMed ID: 31434935
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy and safety of spore-forming probiotics in the treatment of functional dyspepsia: a pilot randomised, double-blind, placebo-controlled trial.
    Wauters L; Slaets H; De Paepe K; Ceulemans M; Wetzels S; Geboers K; Toth J; Thys W; Dybajlo R; Walgraeve D; Biessen E; Verbeke K; Tack J; Van de Wiele T; Hellings N; Vanuytsel T
    Lancet Gastroenterol Hepatol; 2021 Oct; 6(10):784-792. PubMed ID: 34358486
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Resolution of acute gastroenteritis symptoms in children and adults treated with a novel polyphenol-based prebiotic.
    Noguera T; Wotring R; Melville CR; Hargraves K; Kumm J; Morton JM
    World J Gastroenterol; 2014 Sep; 20(34):12301-7. PubMed ID: 25232265
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Outcome-Specific Efficacy of Different Probiotic Strains and Mixtures in Irritable Bowel Syndrome: A Systematic Review and Network Meta-Analysis.
    Xie P; Luo M; Deng X; Fan J; Xiong L
    Nutrients; 2023 Sep; 15(17):. PubMed ID: 37686889
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.